Drug class in one race
5T4 (trophoblast glycoprotein, TPBG) drugs for Non-Small Cell Lung Cancer
3 tracked 5T4 (trophoblast glycoprotein, TPBG) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the 5T4 (trophoblast glycoprotein, TPBG) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1/21 Phase 1
Head-to-head evidence: Naptumomab estafenatox vs TUB-030 · Naptumomab estafenatox vs XB010